Literature DB >> 13679533

Treatment of the antiphospholipid syndrome.

Michael D Lockshin, Doruk Erkan.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 13679533     DOI： 10.1056/NEJMe038131

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

Review 1.  Treatment of the antiphospholipid antibody syndrome.

Authors:  Christopher Wu; Kenneth Kalunian
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

Review 2.  Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons.

Authors:  Eyal Muscal; Robin L Brey
Journal:  Curr Rheumatol Rep       Date:  2008-01       Impact factor: 4.592

Review 3.  Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.

Authors:  Eleni I Kampylafka; Harry Alexopoulos; Marinos C Dalakas; Athanasios G Tzioufas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 4.  The role of antiphospholipid antibodies (aPls) in infertile women: the long-lasting experience.

Authors:  Zdenka Ulcova-Gallova
Journal:  Reprod Med Biol       Date:  2014-10-07

Review 5.  What is antiphospholipid syndrome?

Authors:  Doruk Erkan; Michael D Lockshin
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

6.  Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial.

Authors:  Zhi-Wei Lai; Ryan Kelly; Thomas Winans; Ivan Marchena; Ashwini Shadakshari; Julie Yu; Maha Dawood; Ricardo Garcia; Hajra Tily; Lisa Francis; Stephen V Faraone; Paul E Phillips; Andras Perl
Journal:  Lancet       Date:  2018-03-15       Impact factor: 79.321

7.  Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up.

Authors:  Tunde Tarr; Gabriella Lakos; Harjit Pal Bhattoa; Pal Soltesz; Yehuda Shoenfeld; Gyula Szegedi; Emese Kiss
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

8.  D-dimer level and the risk for thrombosis in systemic lupus erythematosus.

Authors:  Haifeng Wu; Daniel J Birmingham; Brad Rovin; Kevin V Hackshaw; Nabil Haddad; Douglas Haden; Chack-Yung Yu; Lee A Hebert
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

Review 9.  The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome.

Authors:  Reyhan Diz-Kucukkaya; Veysel Sabri Hancer; Bahar Artim-Esen; Yuksel Pekcelen; Murat Inanc
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

10.  Nine-test panel has superior sensitivity to detect antiphospholipid antibody syndrome in patients with or without SLE.

Authors:  Konrad Dziamski; Saika Sharmeen; Katalin Banki; Andras Perl
Journal:  Clin Immunol       Date:  2020-03-19       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.